Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

Delayed Quote. Delayed  - 02/12 04:00:08 pm
63.42 USD   -2.57%
02/04 MEDNAX : revenue up 14 percent in 2015 (BRIEF)
02/04 MEDNAX : tops 4Q profit forecasts
02/04 MEDNAX : Reports Double-Digit Fourth Quarter 2015 Revenue and EPS Gr..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1542 439-3 1303 4283 646
Operating income (EBITDA)492559654693761806
Operating profit (EBIT)452513632615680801
Pre-Tax Profit (EBT)448-----
Net income281317-359400454
P/E ratio19,220,820,016,614,913,5
EPS ( $ )2,783,183,583,824,244,69
Dividend per Share ( $ )------
Yield------
Reference price ( $ )53.3866.1171.6663.4263.4263.42
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt-515-785797-
Finance10,4-----
Operating income (EBITDA)492559654693761806
Leverage
(Debt/EBITDA)
-0,92x-1,13x1,05x-
Capital Expenditure15,618,127,128,231,932,5
Book Value Per Share (BVPS)23,2 $22,6 $25,9 $28,9 $31,0 $34,1 $
Cash Flow per Share4,02 $4,23 $-4,99 $5,57 $5,59 $
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 949 M$ -
Entreprise Value (EV) 6 733 M$ 6 746 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 16,6x 14,9x
Capitalization / Revenue 1,90x 1,74x
EV / Revenue 2,15x 1,97x
EV / EBITDA 9,72x 8,87x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,20x 2,05x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,6% 19,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,12x
Net Margin (Net Profit / Revenue) 11,5% 11,7%
ROA (Net Profit / Asset) 7,60% 7,70%
ROE (Net Profit / Equities) 14,3% 14,0%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   0,90% 0,93%
Cash Flow / Sales 15,0% 15,2%
Capital Intensity (Assets / Sales) 1,51x 1,51x
Financial Leverage (Net Debt / EBITDA) 1,13x 1,05x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend